Duke spin-out raises $5M to accelerate clinical research


The Durham company offers software to help health systems and drugmakers conduct clinical research more efficiently.

Previous Wealth Enhancement Group buys New Jersey firm First Capital Advisors Group
Next Executive who helped lead GE HealthCare IPO joins top ranks at Clarios